Octopus insularis (Cephalopoda: Octopodidae) on the tropical coast of Brazil: where it lives and what it eats

Abstract Octopus insularis is the dominant octopus in the shallow tropical waters of the coast and oceanic islands in the North and Northeast of Brazil. Is the abundance, distribution, habitat and diet of this species on the continent the same as in oceanic islands? These factors were evaluated in seeking these answers at two areas of occurrence of Octopus insularis on the coast of Rio Grande do Norte, Brazil. Three main types of habitats were described where the species is concentrated, being: Deep Reefs (Reefs of Risca) (> 15 m), Flat Biogenic Plateaus (Restingas) (5-15 m) and Shallow Sedimentary Reefs (Pirangi reefs) (< 5 m). An aggregate spatial distribution was verified, along with bathymetric segregation in which small individuals occupied shallow areas. Regarding diet, O. insularis consumed mainly crustaceans (68%) in shallow reef areas, bivalves (86%) in biogenic plateau areas, and gastropods (33%) in deep reef areas. The characterization of new occurring habitats, such as the area of biogenic plateau, and changes in their diet due to habitat function have shown that O. insularis occupies a broader niche than has been described in literature to date, expanding our knowledge on the ecology and biology of this octopus species of economic interest

Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007

This study describes the results of in vitro antimalarial susceptibility assays and molecular polymorphisms of Plasmodium falciparum isolates from Cambodia. The samples were collected from patients enrolled in therapeutic efficacy studies (TES) conducted by the Cambodian National Malaria Control Program for the routine efficacy monitoring of artemisinin-based combination therapy (ACT) (artesunate-mefloquine and artemether-lumefantrine combinations). The isolates (n = 2,041) were obtained from nine sentinel sites during the years 2001 to 2007. Among these, 1,588 were examined for their in vitro susceptibilities to four antimalarials (artesunate, mefloquine, chloroquine, and quinine), and 851 isolates were genotyped for single nucleotide polymorphisms (SNPs). The geometric means of the 50% inhibitory concentrations (GMIC(50)s) of the four drugs tested were significantly higher for isolates from western Cambodia than for those from eastern Cambodia. GMIC(50)s for isolates from participants who failed artesunate-mefloquine therapy were significantly higher than those for patients who were cured (P, >0.001). In vitro correlation of artesunate with the other drugs was observed. The distributions of the SNPs differed between eastern and western Cambodia, suggesting different genetic backgrounds of the parasite populations in these two parts of the country. The GMIC(50)s of the four drugs tested increased significantly in eastern Cambodia during 2006 to 2007. These results are worrisome, because they may signal deterioration of the efficacy of artesunate-mefloquine beyond the Cambodian-Thai borde